[1]
|
Dema, B. and Charles, N. (2014) Advances in Mechanisms of Systemic Lupus Erythematosus. Discovery Medicine, 17, 247-255.
|
[2]
|
Zhou, Q., Liu, J. and Wu, X.D. (2018) Clinical Study on Intrathecal Injection of Combined with Dexa-methasone for Treating Neuropsychiastric Systemic Lupus Erythematsus. China Pharmaceuticals, 27, 21-23.
|
[3]
|
Zhang, Z.R., Meszaros, G., He, W.T., et al. (2017) Protein Kinase D at the Golgi controls NLRP3 In-flammasome Activation. Journal of Experimental Medicine, 214, 2671-2693. https://doi.org/10.1084/jem.20162040
|
[4]
|
Till, S., Jorge, H.M., Eran, E., et al. (2012) Inflammasomes in Health and Disease. Nature, 481, 278-286.
https://doi.org/10.1038/nature10759
|
[5]
|
Guarda, G., Zenger, M., Yazdi, A.S., et al. (2011) Differential Expres-sion of NLRP3 among Hematopoietic Cells. Journal of Immunology, 186, 2529-2534. https://doi.org/10.4049/jimmunol.1002720
|
[6]
|
Eun, K.J., Jin, K.K., Dong, M.S. and Chihiro, S. (2016) Molecular Mechanisms Regulating NLRP3 Inflammasome Activation. Cellular and Molecular Immunology, 13, 148-159. https://doi.org/10.1038/cmi.2015.95
|
[7]
|
Bauernfeind, F. and Hornung, V. (2013) Of Inflammasomes and Path-ogens-Sensing of Microbes by the Inflammasome. EMBO Molecular Medicine, 5, 814 -826. https://doi.org/10.1002/emmm.201201771
|
[8]
|
Stutz, A., Kolbe, C.C., Stahl, R., et al. (2017) NLRP3 Inflam-masome Assembly Is Regulated by Phosphorylation of the Pyrin Domain. Journal of Experimental Medicine, 214, 1725-1736. https://doi.org/10.1084/jem.20160933
|
[9]
|
Asgari, E., Le Friec, G., Yamamoto, H., et al. (2013) C3a Modulates IL-1β Secretion in Human Monocytes by Regulating ATP Efflux and Subsequent NLRP3 Inflammasome Activation. Blood, 122, 3473-3481.
https://doi.org/10.1182/blood-2013-05-502229
|
[10]
|
Chul, S.Y., Dong, M.S. and Eun, K.J. (2012) The Role of NLR-Related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases. International Neurourology Journal, 16, 2-12. https://doi.org/10.5213/inj.2012.16.1.2
|
[11]
|
Jo, E.K., Kim, J.K., Shin, D.M., et al. (2016) Molecular Mechanisms Regulating NLRP3 Inflammasome Activation. Cellular & Molecular Immunology, 13, 148-159. https://doi.org/10.1038/cmi.2015.95
|
[12]
|
Heid, M.E., Keyel, P.A., Kamga, C., et al. (2013) Mitochondrial ROS Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation. The Journal of Immunology, 191, 5230-5238.
https://doi.org/10.4049/jimmunol.1301490
|
[13]
|
Sutterwala, F.S., Haasken, S. and Cassel, S.L. (2014) Mechanism of NLRP3 Inflammasome Activation. Annals of the New York Academy of Sciences, 1319, 82-95. https://doi.org/10.1111/nyas.12458
|
[14]
|
陈斯玲, 陶怡, 陈瑞林. 系统性红斑狼疮患者血清IL-1β和IL-18的表达及意义[J]. 广东医学, 2017, 38(16): 2473-2475.
|
[15]
|
Lu, A.L., Li, H., Niu, J.L., et al. (2017) Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus. The Journal of Immunology, 198, 1119-1129.
https://doi.org/10.4049/jimmunol.1600659
|
[16]
|
Kahlenberg, J.M. and Kaplan, M.J. (2014) The Inflammasome and Lupus: Another Innate Immune Mechanism Contributing to Disease Pathogenesis? Current Opinion in Rheumatology, 26, 475-481.
https://doi.org/10.1097/BOR.0000000000000088
|
[17]
|
Yuan, Y. and Liu, Z. (2015) Isoflurane Attenuates Murine Lupus Nephritis by Inhibiting NLRP3 Inflammasome Activation. International Journal of Clinical and Experimental Medicine, 8, 17730-17738.
|
[18]
|
Meilan, L., Fuzhe, M., Hao, W., et al. (2018) Levels of Serum IL-18 and IL-34 in Pa-tients with Lupus Nephritis and Their Significance. China Journal of Modern Medicine, 28, 53-56.
|
[19]
|
Kahlenberg, J.M., Yalavarthi, S., Zhao, W., et al. (2014) An Essential Role for Caspase-1 in the Induction of Murine Lupus and Its Associated Vascular Damage. Arthritis & Rheumatology, 66, 153-162. https://doi.org/10.1002/art.38225
|
[20]
|
Wang, Y.Y., Li, H.T., Lu, Y., et al. (2017) Protective Effects of Glycyr-rhizic Acid against Lupus Nephritis in MRL/lpr Mice. Journal of Southern Medical University, 37, 957-961.
|
[21]
|
Ma, X.L., Gong, Y., Zhu, H., et al. (2010) Analysis on Clinical Features and Curative Effect in Patients with Neuropsychiaric Systemic Lupus Erythematosus. Ningxia Medical Journal, 32, 134-136.
|
[22]
|
Wang, L.L., Wang, J.B., Liang, H.D., et al. (2014) Role of IL-1β, IL-6, IL-8 and IFN-γ to CNS-NPSLE Pathogenesis. Chinese Journal of Immunology, 30, 247-251.
|
[23]
|
Gottschalk, T.A., Tsantikos, E. and Hibbs, M.L. (2015) Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus. Frontiers in Immunology, 6, 550. https://doi.org/10.3389/fimmu.2015.00550
|
[24]
|
Long, J.H., Yin, P.Z., Yun, L.C., et al. (2018) The Relationship between NLRP3 Inflammasome and Coronary Heart Disease. Chinese Journal of Arteriosclerosis, 26, 281-286.
|
[25]
|
Yi, X.L., Jian, M., Yang, W., et al. (2018) Role of NLRP3 Inflammasome in Diabetic Nephropathy Inflammatory Mechanisms. Journal of Liaoning University of TCM, 20, 126-128.
|
[26]
|
刘一鹏, 欧宗兴. NLRP3炎性小体与呼吸系统疾病的关系[J]. 海南医学, 2018, 29(2): 224-226.
|
[27]
|
范慧敏, 胡容. 炎症小体在肿瘤中的双重作用[J]. 药物生物技术, 2017, 24(2): 155-158.
|